[1]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,(24):82-83,86.[doi:10.3969/j.issn.1006-1959.2018.24.021]
　ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Medical Information,2018,(24):82-83,86.[doi:10.3969/j.issn.1006-1959.2018.24.021]
点击复制

血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年24期
页码:
82-83,86
栏目:
临床研究
出版日期:
2018-12-15

文章信息/Info

Title:
Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer
文章编号:
1006-1959（2018）24-0082-03
作者:
赵 静
九江市第一人民医院消化内科，江西 九江 332000
Author(s):
ZHAO Jing
Department of Gastroenterology,Jiujiang First People's Hospital,Jiujiang 332000,Jiangxi,China
关键词:
胃癌; 胃良性病变; 纤维蛋白原; 糖类抗原724
Keywords:
Gastric cancer; Benign gastric lesions; Fibrinogen; Carbohydrate antigen 724
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2018.24.021
文献标志码:
A
摘要:
目的 探讨血浆纤维蛋白原（FIB）和糖类抗原724（CA724）水平在胃癌的变化及临床意义。方法 选取我院2015年1月~2017年12月经病理证实的胃癌患者50例设为胃癌组，另选30例胃良性病变患者设为胃良性病变组，30例健康体检者设为对照组，比较各组血浆FIB和CA724水平及联合检测在胃癌患者中的变化。结果 胃癌组患者血浆FIB和CA724水平［（6.12±1.55）g/L、（43.76±6.29）ng/ml）］高于对照组［（2.87±0.54）g/L、（2.41±0.26）U/ml）］，差异具有统计学意义（P＜0.05），胃良性病变病变血浆FIB水平（3.46±0.75）g/L高于对照组，差异具有统计学意义（P＜0.05），而CA724水平（3.66±0.73）ng/ml与对照组比较，差异无统计学意义（P＞0.05）；胃癌组血浆FIB和CA724联合检测高于单项检测，差异具有统计学意义（P＜0.05）。结论 血浆FIB和CA724水平有助于协助诊断胃癌，且两者联合检测能提高胃癌患者诊断敏感性和准确性。
Abstract:
Objective To investigate the changes and clinical significance of plasma fibrinogen (FIB) and carbohydrate antigen 724 (CA724) levels in gastric cancer. Methods A total of 50 patients with gastric cancer confirmed by pathology from January 2015 to December 2017 were enrolled as gastric cancer group. 30 patients with benign gastric lesions were selected as benign gastric lesions, and 30 healthy subjects were selected as control group. Changes in plasma FIB and CA724 levels and combined detection in patients with gastric cancer. Results The plasma levels of FIB and CA724[(6.12±1.55)g/L,(43.76±6.29)ng/ml)]were higher in the gastric cancer group than in the control group[(2.87±0.54)g/L,(2.41±0.26)U/ml],the difference was statistically significant(P<0.05), plasma FIB level (3.46±0.75)g/L in benign gastric lesions was higher than that in the control group, the difference was statistically significant (P<0.05), while CA724 level (3.66±0.73)ng/ml was compared with the control group. There was no significant difference between the two groups (P>0.05). The combined detection of FIB and CA724 in the gastric cancer group was higher than that in the single item,the difference was statistically significant (P<0.05). Conclusion The levels of plasma FIB and CA724 can help to diagnose gastric cancer, and the combined detection can improve the sensitivity and accuracy of gastric cancer patients.

参考文献/References:

[1]冯慧远,刘培永,李振华,等.腹腔镜下与开腹胃切除术治疗早期胃癌的临床效果分析[J].中华消化病与影像杂志（电子版）,2015(4):31-34.
[2]郑加荣,张敏,徐日,等.肿瘤标记物联合动态监测在胃癌诊断和监控治疗中的临床应用[J].中华临床医师杂志(电子版),2015,9(3):382-386.
[3]王利平.晚期胃癌患者凝血功能指标和和D-二聚体水平的检测分析[J].微循环学杂志,2012,22(2):79.
[4]刘中娟,张瑞丽,刘娟娟,等.多种血清肿瘤标志物联合检测对胃癌辅助诊断的研究[J].标记免疫分析与临床,2016,23(1):1-4.
[5]王翔,张雨洁.恶性肿瘤患者凝血功能异常的研究进展[J].现代肿瘤医学,2016,24(8):1325-1328．
[6]黄武浩,张华,王长利.术前纤维蛋白原联合淋巴细胞与单核细胞比值对非小细胞肺癌患者预后的评估价值[J].中国肿瘤临床,2017,44(17):857-862.
[7]杨之敏,邱堃,王静.胃癌患者凝血功能与病理特征的关系探讨[J].中国实验诊断学,2016,20(9):1480-1482.
[8]Liu L,Zhang X,Yan B,et al.Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients[J].PLoS One,2014,9(3):e90547．
[9]幸茂晖,陈典.联合检测肿瘤标记物对胃癌进行早期诊断的临床研究[J].河北医药,2011,23(2):618-621.
[10]吴明亚.浅析CA15-3、CEA和CA724检测在诊断乳腺癌中的价值[J].当代医药论丛,2015,13(13):39-40.

相似文献/References:

[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
　YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,(24):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
　RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Medical Information,2018,(24):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
　DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Medical Information,2018,(24):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
　PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Medical Information,2018,(24):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2018,(24):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[6]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
　LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Medical Information,2018,(24):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[7]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
　MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Medical Information,2018,(24):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[8]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
　WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[9]牛 悦,白建平,卢建跃.HER-2阳性胃癌的研究进展[J].医学信息,2019,(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
　NIU Yue,BAI Jian-ping,LU Jian-yue.Progress in Research of HER-2 Positive Gastric Cancer[J].Medical Information,2019,(24):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
[10]张 印,张 军.进展期胃癌淋巴结清扫研究进展[J].医学信息,2019,(07):57.[doi:10.3969/j.issn.1006-1959.2019.07.018]
　ZHANG Yin,ZHANG Jun.Progress in Lymph Node Dissection of Advanced Gastric Carcinoma[J].Medical Information,2019,(24):57.[doi:10.3969/j.issn.1006-1959.2019.07.018]

更新日期/Last Update: 2019-01-09